Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1950-1956

  Lepore, John J ^a,b   Dec, G William ^a   Zapol, Warren M ^a   Bloch, Kenneth D ^a   Semigran, Marc J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; OXYGEN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART GRAFT; HEART INDEX; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; ADULT; AGED; BLOOD PRESSURE; DIPYRIDAMOLE; DRUG COMBINATIONS; FEMALE; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PULMONARY ARTERY; VASCULAR RESISTANCE;

EID: 27844570440     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.04.007     Document Type: Article

References (34)

1. R.B. Griepp, E.B. Stinson, E. Dong Jr, D.A. Clark, N.E. Shumway Determinants of operative risk in human heart transplantation Am J Surg 122 1971 192 197
2. J.K. Kirklin, D.C. Naftel, J.W. Kirklin, E.H. Blackstone, C. White-Williams, R.C. Bourge Pulmonary vascular resistance and the risk of heart transplantation J Heart Transplant 7 1988 331 336
3. The Transplant Cardiologists Research Database Group R.C. Bourge, D.C. Naftel, M.R. Costanzo-Nordin Pretransplantation risk factors for death after heart transplantation a multiinstitutional study J Heart Lung Transplant 12 1993 549 562
4. M.E. Natale, I.L. Pina Evaluation of pulmonary hypertension in heart transplant candidates Curr Opin Cardiol 18 2003 136 140
5. A. Costard-Jackle, M.B. Fowler Influence of preoperative pulmonary artery pressure on mortality after heart transplantation testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group JAMA 19 1992 48 54
6. J.M. Chen, H.R. Levin, R.E. Michler, C.J. Prusmack, E.A. Rose, K.D. Aaronson Reevaluating the significance of pulmonary hypertension before cardiac transplantation determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality J Thorac Cardiovasc Surg 114 1997 627 634
7. S.V. Pamboukian, R.G. Carere, J.G. Webb The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension J Heart Lung Transplant 18 1999 367 371
8. J.A. Hill, K. Hsu, D.F. Pauly, R. Schofield, J.M. Aranda Jr Sustained use of nesiritide to aid in bridging to heart transplant Clin Cardiol 26 2003 211 214
9. G.A. Haywood, J.F. Sneddon, Y. Bashir, S.H. Jennison, H.H. Gray, W.J. McKenna Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure. A good test but a poor therapy Circulation 86 1992 896 902
10. S. Murali, B.F. Uretsky, J.M. Armitage Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension J Heart Lung Transplant 11 1992 716 723
11. S. Klotz, M.C. Deng, D. Hanafy Reversible pulmonary hypertension in heart transplant candidates - pretransplant evaluation and outcome after orthotopic heart transplantation Eur J Heart Fail 5 2003 645 653
12. M.W. Weston, B.F. Isaac, C. Crain The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension J Heart Lung Transplant 20 2001 1340 1344
13. A. Haraldsson, N. Kieler-Jensen, U. Nathorst-Westfelt, C.H. Bergh, S.E. Ricksten Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 1998 780 786
14. A. Sablotzki, T. Hentschel, E. Gruenig Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance Eur J Cardiothorac Surg 22 2002 746 752
15. W. Steudel, W.E. Hurford, W.M. Zapol Inhaled nitric oxide basic biology and clinical applications Anesthesiology 91 1999 1090 1121
16. G.L. Yung, J.M. Kriett, S.W. Jamieson Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis a bridge to lung transplantation J Heart Lung Transplant 20 2001 1224 1227
17. D.N. Cornfield, C.E. Milla, I.Y. Haddad, J.E. Barbato, S.J. Park Safety of inhaled nitric oxide after lung transplantation J Heart Lung Transplant 22 2003 903 907
18. M.J. Semigran, B.A. Cockrill, R. Kacmarek Hemodynamic effects of inhaled nitric oxide in heart failure JAMA 24 1994 982 988
19. E. Loh, J.S. Stamler, J.M. Hare, J. Loscalzo, W.S. Colucci Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction Circulation 90 1994 2780 2785
20. I. Adatia, S. Perry, M. Landzberg, P. Moore, J.E. Thompson, D.L. Wessel Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation JAMA 25 1995 1656 1664
21. F. Ichinose, C. Adrie, W.E. Hurford, K.D. Bloch, W.M. Zapol Selective pulmonary vasodilation induced by aerosolized zaprinast Anesthesiology 88 1998 410 416
22. J.W. Ziegler, D.D. Ivy, J.J. Fox, J.P. Kinsella, W.R. Clarke, S.H. Abman Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus Am J Respir Crit Care Med 157 1998 1104 1110
23. L. Foubert, D. De Wolf, K. Mareels Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets Pediatr Res 52 2002 730 736
24. J.W. Ziegler, D.D. Ivy, J.W. Wiggins, J.P. Kinsella, W.R. Clarke, S.H. Abman Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension Am J Respir Crit Care Med 158 1998 1388 1395
25. D.A. Fullerton, J. Jaggers, F. Piedalue, F.L. Grover, R.C. McIntyre Jr Effective control of refractory pulmonary hypertension after cardiac operations J Thorac Cardiovasc Surg 113 1997 363 368
26. D.D. Ivy, J.P. Kinsella, J.W. Ziegler, S.H. Abman Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease J Thorac Cardiovasc Surg 115 1998 875 882
27. Y. Saiki, Y. Nitta, Y. Tsuru, K. Tabayashi Successful weaning from inhaled nitric oxide using dipyridamole Eur J Cardiothorac Surg 24 2003 837 839
28. J.J. Lepore, A. Maroo, N.L. Pereira Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension Am J Cardiol 90 2002 677 680
29. A. Ranhosky, J. Kempthorne-Rawson The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous dipyridamole thallium imaging study group Circulation 81 1990 1205 1209
30. C. Mahony, K.M. Wolfram, D.M. Cocchetto, T.D. Bjornsson Dipyridamol kinetics Clin Pharmacol Ther 31 1982 330 338
31. J.M. Hare, S.K. Shernan, S.C. Body, E. Graydon, W.S. Colucci, G.S. Couper Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance Circulation 95 1997 2250 2253
32. M. Packer, R. Gorlin, J. Meller, N. Medina Central hemodynamic effects of dipyridamole in severe heart failure comparison with hydralazine Clin Pharmacol Ther 32 1982 54 61
33. G.A. Fitzgerald Dipyridamole N Engl J Med 316 1987 1247 1257
34. M.R. Costanzo, S. Augustine, R. Bourge Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation 92 1995 3593 3612